{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Hazelwood",
      "state": "MO",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Devices",
      "event_id": "72760",
      "recalling_firm": "Biomerieux Inc",
      "address_1": "595 Anglum Rd",
      "address_2": "N/A",
      "postal_code": "63042-2320",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "US Distribution to states of: CA, GA, IN, MA, MN, MO, NY, OH and PA.",
      "recall_number": "Z-0556-2016",
      "product_description": "Granada Biphasic Broth    The product is a selective medium for the screening and identification of Streptococcus agalactiae in pregnant women using clinical specimens.",
      "product_quantity": "24 cartons",
      "reason_for_recall": "FDA has determined that the product requires 510(k) clearance to continue marketing/distribution in the United States.",
      "recall_initiation_date": "20151123",
      "center_classification_date": "20151229",
      "termination_date": "20160224",
      "report_date": "20160106",
      "code_info": "REF 42722 - Lot Numbers 896, 897 & 899"
    }
  ]
}